![]() Antidote Antidote is accelerating the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. | ![]() ObsEva ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine. | ![]() Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | ![]() Recro Gainesville Recro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain. | ![]() Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date 2009 | Founding Date 2012 | Founding Date 1981 | Founding Date 2006 | Founding Date 1998 |
Type | Type Private | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations London, GB HQ Carmel, US New York, US | Locations Plan-les-Ouates, CH HQ Boston, US Sacramento, US | Locations Tustin, US HQ | Locations Gainesville, US HQ Gainesville, US | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 645% increase | Employees 524% decrease | Employees 21114% increase | Employees 21316% decrease | Employees 29843% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 848 m | Valuation ($) 97.4 m | Valuation ($) N/A |
Alexa Website Rank | Alexa Website Rank 234574 | Alexa Website Rank 103932 | Alexa Website Rank 569070 | Alexa Website Rank 605579 | Alexa Website Rank N/A |
Employee Rating | Employee Rating 4 | Employee Rating N/A | Employee Rating 3 | Employee Rating 4.1 | Employee Rating 3.5 |
Financial | |||||
Revenue (est.) | Revenue (est.) £1.5m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $59.7m (FY, 2020) | Revenue (est.) $66.5m (FY, 2020) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods £1.1m (FY, 2018) | Cost of goods N/A | Cost of goods $55.8m (FY, 2020) | Cost of goods $54.1m (FY, 2020) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit £447.6k (FY, 2018) | Gross profit N/A | Gross profit $3.9m (FY, 2020) | Gross profit $12.4m (FY, 2020) | Gross profit $114.4m (FY, 2018) |
Net income | Net income (£5.3m) (FY, 2018) | Net income N/A | Net income ($10.5m) (FY, 2020) | Net income ($27.5m) (FY, 2020) | Net income ($147.7m) (FY, 2018) |
Funding | |||||
Latest funding round | Latest funding round $ 23m (12 months ago) | Latest funding round $ 60m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 40.9m | Total funding raised $ 92.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |
ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.
View companyAvid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View companyRecro Gainesville (also known as Recro Pharma) is a clinical-stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of acute post-operative pain.
View companyArray BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company